Michelle Andrews

Michelle Andrews is a contributing writer and former columnist for KFF Health News. She has been writing about health care for more than 15 years. Her work has appeared frequently in The New York Times, where she wrote the Money and Medicine column and contributed regular news and features. Her work has also been published in Money, Fortune Small Business, National Geographic and Women’s Health magazines, among others. Michelle previously worked as a senior writer at U.S. News & World Report and at SmartMoney magazines. She has a bachelor’s degree from the University of Wisconsin and a master’s in journalism from Columbia University.

Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills

Under the Affordable Care Act, insurers cannot charge consumers for various preventive services that have been recommended by experts. But if those screenings indicate more testing is needed to determine whether something is wrong, patients may be on the hook for hundreds or even thousands of dollars for diagnostic services.

Why So Slow? Legislators Take on Insurers’ Delays in Approving Prescribed Treatments

Insurers say prior authorization requirements are intended to reduce wasteful and inappropriate health care spending. But they can baffle patients waiting for approval. And doctors say that insurers have yet to follow through on commitments to improve the process.

Washington State Retools First-in-the-Nation Long-Term Care Benefit

The WA Cares Fund program, which would provide workers in the state a lifetime benefit of $36,500, was set to begin collecting money through a payroll tax in January, but it was delayed while lawmakers made adjustments to address equity problems. Now the payroll deductions will begin in July 2023, and benefits will become available in 2026.

Despite Doctors’ Concerns, Pharmacists Get More Leeway to Offer Treatment With Testing

In the battle against covid, pharmacies became a key place for consumers to seek vaccines and testing. Some states are expanding pharmacists’ work to include directly prescribing drugs for customers who seek some routine, point-of-care tests, such as those for flu or strep throat. But doctor groups oppose the move.

Officials Struggle to Regulate Pop-Up Covid Testing Sites — And Warn Patients to Beware

High demand for covid screening and scarce supply have opened the door to bad actors, and officials in some states are sounding the alarm about dubious street testing operators that could put people’s personal data, their health or wallets at risk.